期刊文献+

重症肌无力患者胸腺细胞及外周血淋巴细胞Fas表达研究

Study on Fas Expression of Thymocyte and Peripheral Blood Lymphocyte of Patients with Myasthenia Gravis
下载PDF
导出
摘要 目的 探讨重症肌无力(MG)的发病机制。方法 采用流式细胞术(FCM)分别检测MG患者胸腺细胞、外周血淋巴细胞(PBL)及地塞米松培养胸腺细胞的Fas表达。结果 MG患者PBL CD4、CD8细胞Fas表达率(分别为49%,34%;39%,34%)与对照组(分别为58%,25%;49%,24%)相比差异无显著性;MG患者胸腺细胞Fas表达率(11.20%,6.13%)较对照组(6.15%,1.84%)明显增高;地塞米松培养组Fas表达率MG组、正常人组分别为11.54%、8.62%和7.08%、3.13%,与空白对照组(MG组、正常人组分别为11.36%、6.87%和7.22%、2.86%)相比差异无显著性。结论 MG患者PBL,CD4、CD8细胞Fas表达率无明显增高,可能与自身反应淋巴细胞Fas和PBL FasL结合,发生程序化死亡有关。MG患者胸腺细胞Fas表达增高,可能参与MG发病机制。 Objective To investigate the pathogenesis of myasthenia gravis(MG). Methods Flow cytome-try(FCM) was adopted to examine the Fas expressions of thymocytes and peripheral blood lymphocytes (PBLs) of MG. Results There was no sigificant difference in the proportions of Fas+ PEL between MG patients(49% , 34%;39%,34% in CD4, CD8 respectively) and controls (58% ,25% ;49% , 24% in CD4, CD8 respectively). The proportion of Fas+ thymocytes of MG(11. 20% ,6. 13%) was significantly higher( P <0. 01) than controls (6. 15% .1. 84%). Both in MG and normal human Fas+ thymocytes, there was no significant difference( P > 0.05) between dexamethasone groups (11. 54% , 8. 62% ; 7. 08% , 3. 13% in MG, normal human respectively) and control groups(11. 36%,6. 87%;7. 22%,2. 86% in MG, normal human respectively). Conclusions The proportions of Fas+ in CD4, CD8 of MG were not significantly different from controls which might be associated with the correction of FasL of PBL. The proportion of Fas+ thymocytes of MG was significantly increased which might be involved in the pathogenesis of MG.
出处 《中国神经免疫学和神经病学杂志》 CAS 2003年第4期226-229,共4页 Chinese Journal of Neuroimmunology and Neurology
关键词 重症肌无力 胸腺细胞 外周血 淋巴细胞 FAS 发病机制 流式细胞术 myasthenia gravis thymocyte peripheral blood lymphocyte Fas/Apo-1/CD95 three-colour flow-cymetry
  • 相关文献

参考文献10

  • 1张劭夫,刘树芬,张波,徐军,高长兴.支气管哮喘淋巴细胞Fas抗原的表达[J].中华结核和呼吸杂志,1998,21(4):227-228. 被引量:7
  • 2岳岚,宋作珪,柴,沈钢.获得性自身免疫性重症肌无力患者胸腺组织Bcl-2和Fas表达水平的研究[J].浙江医学,1999,21(6):321-323. 被引量:2
  • 3殷伟,乔健,吕传真.重症肌无力实验模型中胸腺细胞凋亡及其机制的研究[J].上海免疫学杂志,2000,20(1):44-46. 被引量:6
  • 4Kawanami S, Mori S, Kikuchi M, et al. Fas and nicotinic acetylcholine receptor in human myasthenia thymus-immunochemical study[J]. Fukuoka Igaku Zasshi, 1999,90(6) .286-294.
  • 5Leprince C, Cohen-Kaminsky S, Berrih-Aknin S, et al. Thymic B cells from myasthenia gravis patients are activated B cells, phenotypic and functional analysis[J]. J immunol, 1990,145 (7) : 2115-2122.
  • 6Ju ST,Panka DJ, Cui H , et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation[J]. Nature, 1995,373: 444-448.
  • 7Moulian N,Bidaulf J,Truffault F, et al. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody[J].Blood, 1997,89 (9) : 3287-3295.
  • 8Utsugisawa K, Yamagata M,Saitoh K, et al. Fas antigen gene in thymuses from patients with myasthenia gravis[J]. Rinsho Shinkeigaku, 1995,35(2)121-125.
  • 9Masunaga A,Arai T, Yoshitake T, et al. Reduced expression of apoptosis-related antigen in thymuses from patients with myasthenia gravis[J]. Immunol Lett, 1994,39(2): 169-172.
  • 10Debatin KM,Suss D,Krammer PH, et al. Differential expression of Apo-1 on human thymocytes: implication for negative selection? [J]. Eur J Immunol,1994,24(3) :753-758.

二级参考文献3

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部